Literature DB >> 24240972

Expectant versus surgical management of first-trimester miscarriage: a randomised controlled study.

Wael Al-Ma'ani1, Erich-Franz Solomayer, Mohamad Hammadeh.   

Abstract

INTRODUCTION: The aim of this study is to compare the efficacy and safety of expectant management with surgical management of first-trimester miscarriage.
METHODS: This randomised prospective study was conducted in the Gynaecology Department at University of Saarland Hospital, Germany between February 2011 and April 2012. A total of 234 women were recruited following diagnosis of the first-trimester incomplete or missed miscarriage and randomised into two groups: 109 women were randomised to expectant management (group I), and 125 women to surgical management (groupII). All women were examined clinically and sonographically during the follow-up appointments at weekly intervals for up to 4 weeks as appropriate. The outcome measures were: efficacy, short-term complications and duration of vaginal bleeding and pain.
RESULTS: Of 234 eligible women, 17 were lost to follow-up, and the remaining 217 women were analysed. The baseline characteristics were similar in both groups. The total success rate at 4 weeks was lower for expectant than for surgical management (81.4 vs 95.7 %; P = 0.0029). The type of miscarriage was a significant factor affecting the success rate. For missed miscarriage, the success rates for expectant versus surgical management were 75 and 93.8 %, respectively. For women with incomplete miscarriage, the rates were 90.5 and 98 %. No differences were found in the number of emergency curettages between the two study groups. The duration of bleeding was significantly more in the expectant than the surgical management (mean 11 vs 7 days; P < 0.0001). The duration of pain was also more in the expectant than the surgical group (mean 8.1 vs 5.5 days; P < 0.0001). The total complication rates were similar in both groups (expectant 5.9 % vs surgical group 6.1 %; P = 0.2479). However, the pelvic infection was significantly lower in the expectant than the surgical group (1.9 vs 3.5 %, respectively; P = 0.0146).
CONCLUSION: Expectant management of clinically stable women with first-trimester miscarriage is safe and effective and avoids the need for surgery and the subsequent risk of anaesthesia in about 81.4 % of cases, and has lower pelvic infection rate than surgical curettage. However, surgical management is more successful, and with a shorter duration of bleeding and pain. Therefore, the patient's preference should be considered in the counselling process.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24240972     DOI: 10.1007/s00404-013-3088-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

1.  [Expectant therapy versus curettage for retained products of conception after second trimester termination of pregnancy: analysis of outcomes and complications].

Authors:  Wen-Juan Zeng; Sheng-Li An; Hao Huang; Qi-Tao Huang; Fei-Feng Li; Hai-Zhen Wang; Dan-Chun Cai; Yun-Fei Gao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

2.  Expectant Versus Surgical Management of Early Pregnancy Miscarriages- A Prospective Study.

Authors:  Reshma Sajan; Mumtaz Pulikkathodi; Abdul Vahab; Valsan Mankara Kunjitty; Hassan Sheikh Imrana
Journal:  J Clin Diagn Res       Date:  2015-10-01

3.  Expectant management of miscarriage in view of NICE Guideline 154.

Authors:  Junaid Rafi; Haroona Khalil
Journal:  J Pregnancy       Date:  2014-04-27

4.  Case Report: Group B Streptococcus meningitis in an adolescent  .

Authors:  Roselle Vittorino; Joyce Hui-Yuen; Adam J Ratner; Amy Starr; Teresa McCann
Journal:  F1000Res       Date:  2014-07-22

5.  Fertility after recurrent miscarriages: results of an observational cohort study.

Authors:  Christiane Kling; Jürgen Hedderich; Dieter Kabelitz
Journal:  Arch Gynecol Obstet       Date:  2017-10-16       Impact factor: 2.344

Review 6.  The use of intra-operative ultrasound in gynecological surgery: a review.

Authors:  Karen Grewal; Benjamin Jones; Ariadne L'Heveder; Sita Jindal; Nicolas Galazis; Srdjan Saso; Joseph Yazbek
Journal:  Future Sci OA       Date:  2021-01-12

7.  Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial.

Authors:  Charlotte Hamel; Sjors Coppus; Joyce van den Berg; Esther Hink; Jacoba van Seeters; Paul van Kesteren; Ashley Merién; Bas Torrenga; Rafli van de Laar; Josien Terwisscha van Scheltinga; Ingrid Gaugler-Senden; Peppino Graziosi; Minouche van Rumste; Ewka Nelissen; Frank Vandenbussche; Marcus Snijders
Journal:  EClinicalMedicine       Date:  2021-01-06

8.  Methods for managing miscarriage: a network meta-analysis.

Authors:  Jay Ghosh; Argyro Papadopoulou; Adam J Devall; Hannah C Jeffery; Leanne E Beeson; Vivian Do; Malcolm J Price; Aurelio Tobias; Özge Tunçalp; Antonella Lavelanet; Ahmet Metin Gülmezoglu; Arri Coomarasamy; Ioannis D Gallos
Journal:  Cochrane Database Syst Rev       Date:  2021-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.